Rowland Carmichael Advisors’s Gilead Sciences GILD Stock Holding History

Rowland Carmichael Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$797K	Sell	13,680 -135	-1%	-$8.15K	0.25%	92
2020 Q3	$873K	Buy	13,815 +80	+0.6%	+$5.55K	0.34%	76
2020 Q2	$1.06M	Sell	13,735 -27	-0.2%	-$2.07K	0.45%	49
2020 Q1	$1.03M	Buy	13,762 +75	+0.5%	+$5.18K	0.52%	36
2019 Q4	$889K	Sell	13,687 -114	-0.8%	-$7.42K	0.31%	90
2019 Q3	$875K	Buy	13,801 +201	+1%	+$13.1K	0.3%	87
2019 Q2	$919K	Hold	13,600	–	–	0.32%	78
2019 Q1	$884K	Hold	13,600	–	–	0.32%	79
2018 Q4	$851K	Hold	13,600	–	–	0.38%	52
2018 Q3	$1.05M	Hold	13,600	–	–	0.41%	55
2018 Q2	$963K	Hold	13,600	–	–	0.41%	56
2018 Q1	$1.02M	Hold	13,600	–	–	0.56%	41
2017 Q4	$974K	Sell	13,600 -50	-0.4%	-$3.8K	0.5%	54
2017 Q3	$1.11M	Hold	13,650	–	–	0.61%	36
2017 Q2	$966K	Hold	13,650	–	–	0.56%	47
2017 Q1	$927K	Hold	13,650	–	–	0.56%	45
2016 Q4	$977K	Hold	13,650	–	–	0.58%	53
2016 Q3	$1.08M	Hold	13,650	–	–	0.69%	42
2016 Q2	$1.14M	Hold	13,650	–	–	0.72%	33
2016 Q1	$1.25M	Buy	+13,650	New	+$1.23M	1.16%	18

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rowland Carmichael Advisors's GILD Position: Q4 2020 in Review

Rowland Carmichael Advisors reduced its Gilead Sciences (GILD) stake by 0.98% in Q4 2020, selling an estimated $8.15K and leaving 13,680 shares worth $797K. The position accounts for 0.25% of the portfolio, ranked #92.

Rowland Carmichael Advisors first reported a position in GILD in Q1 2016 and has held it in 20 quarters since. The position peaked at $1.25M in Q1 2016. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Rowland Carmichael Advisors held 13,680 shares of Gilead Sciences worth $797K as of Q4 2020.
Rowland Carmichael Advisors sold 135 Gilead Sciences shares in Q4 2020, an estimated $8.15K.
Gilead Sciences made up 0.25% of Rowland Carmichael Advisors's portfolio in Q4 2020, its #92 holding.
Rowland Carmichael Advisors first reported a position in Gilead Sciences in Q1 2016 and has held it in 20 quarters since.
Rowland Carmichael Advisors's Gilead Sciences position peaked at $1.25M in Q1 2016.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Rowland Carmichael Advisors's 13F filing for Q4 2020, filed 15 Jan 2021.